Browsing: Volume 2 Issue 5 – May 2026

Longevity and Mortality Investor’s Editor’s Letter for the May 2026 issue.

New Prudential Regulation Authority consultation paper spells out the new capital charge for funded reinsurance deals.

Origination values in the proprietary reverse mortgage market in the US have exceeded the agency-backed market for the first time.

Both micro and macro impacts for life settlement market but counterparty fundamentals remain strong.

For life settlement markets, earlier diagnosis of chronic diseases may reduce projected life expectancy, thereby influencing the expected duration of premium payments and the timing of policy maturities.

The total number of life insurance policies purchased in the life settlement industry’s secondary market grew 10.2% from 2,697 in 2024 to 2,972 in 2025, according to new data published by life settlement provider, Coventry.

Third-party capital in the asset intensive life reinsurance market now sits at all-time highs, but just how much higher can it go?

Business may be brisk in the UK pension risk transfer market, but human capital constraints mean lower activity than is potentially possible.

Greg Winterton spoke to Daniel Taylor, Client Director at Trafalgar House, to explore the essential priorities for trustees navigating the complex path toward de-risking.